Alyssa Sheih

1.3k total citations · 1 hit paper
21 papers, 699 citations indexed

About

Alyssa Sheih is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Alyssa Sheih has authored 21 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 9 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Alyssa Sheih's work include CAR-T cell therapy research (15 papers), Biosimilars and Bioanalytical Methods (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Alyssa Sheih is often cited by papers focused on CAR-T cell therapy research (15 papers), Biosimilars and Bioanalytical Methods (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Alyssa Sheih collaborates with scholars based in United States, Canada and South Africa. Alyssa Sheih's co-authors include Stanley R. Riddell, Cameron J. Turtle, Reed M. Hawkins, David G. Maloney, Steven F. Ziegler, Rachel N. Steinmetz, Barbara S. Pender, Jordan Gauthier, Alexandre V. Hirayama and Aesha Vakil and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Alyssa Sheih

21 papers receiving 693 citations

Hit Papers

Feasibility and efficacy of CD19-targeted CAR T cells wit... 2020 2026 2022 2024 2020 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure
    2020 227 citations Jordan Gauthier, Alexandre V. Hirayama et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alyssa Sheih United States 9 440 233 217 136 117 21 699
Tatsunori Goto Japan 14 435 1.0× 240 1.0× 216 1.0× 146 1.1× 19 0.2× 48 723
Alexander Jares United States 10 495 1.1× 393 1.7× 242 1.1× 190 1.4× 68 0.6× 10 713
May Daher United States 16 631 1.4× 629 2.7× 275 1.3× 102 0.8× 37 0.3× 38 1.0k
Sibylle Pscherer Germany 14 545 1.2× 490 2.1× 102 0.5× 131 1.0× 31 0.3× 19 747
Christos Georgiadis United Kingdom 11 432 1.0× 140 0.6× 377 1.7× 246 1.8× 29 0.2× 21 664
Jessica Hartmann Germany 16 864 2.0× 483 2.1× 471 2.2× 379 2.8× 29 0.2× 25 1.2k
Pranay D. Khare United States 10 408 0.9× 197 0.8× 193 0.9× 188 1.4× 48 0.4× 17 701
Michael J. Kadan United States 11 410 0.9× 114 0.5× 440 2.0× 357 2.6× 33 0.3× 16 828
Katrin Töpfer Germany 11 655 1.5× 536 2.3× 246 1.1× 141 1.0× 12 0.1× 12 896
Ruth A. Salmon Canada 7 205 0.5× 180 0.8× 230 1.1× 50 0.4× 38 0.3× 15 473

Countries citing papers authored by Alyssa Sheih

Since Specialization
Citations

This map shows the geographic impact of Alyssa Sheih's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alyssa Sheih with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alyssa Sheih more than expected).

Fields of papers citing papers by Alyssa Sheih

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alyssa Sheih. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alyssa Sheih. The network helps show where Alyssa Sheih may publish in the future.

Co-authorship network of co-authors of Alyssa Sheih

This figure shows the co-authorship network connecting the top 25 collaborators of Alyssa Sheih. A scholar is included among the top collaborators of Alyssa Sheih based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alyssa Sheih. Alyssa Sheih is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brandes, Alissa, A. Koo, Kathryn Michels, et al.. (2024). Nonclinical Toxicology, Biodistribution, and Pharmacokinetics of UB-VV111, an In Vivo Anti-CD19 CAR T Cell Therapy. Blood. 144(Supplement 1). 2046–2046. 1 indexed citations
2.
Zheng, Ye, Janaki Purushe, Jay F. Sarthy, et al.. (2024). Histone marks identify novel transcription factors that parse CAR-T subset-of-origin, clinical potential and expansion. Nature Communications. 15(1). 8309–8309. 4 indexed citations
3.
Nicolai, Christopher J., Seungjin Shin, Jim Qin, et al.. (2024). 1145 Development of a surface engineered lentiviral vector for in vivo generation of CD22-directed CAR T cells. Regular and Young Investigator Award Abstracts. A1267–A1267. 1 indexed citations
4.
Brandes, Alissa, Susana Hernández, Christopher J. Nicolai, et al.. (2023). 438 In vivo Engineered CAR-T cells for oncology using a surface-engineered lentivirus platform: nonclinical safety and biodistribution. SHILAP Revista de lepidopterología. A487–A487. 1 indexed citations
5.
Sheih, Alyssa, Salvatore Fiorenza, Alexandre V. Hirayama, et al.. (2021). Recombinant CD19 Glycomutant Accurately and Reproducibly Detects CD19-Directed CAR-T Cells By Flow Cytometry. Blood. 138(Supplement 1). 1724–1724. 1 indexed citations
6.
Hirayama, Alexandre V., Ye Zheng, Mark R. Dowling, et al.. (2021). Long-Term Follow-up and Single-Cell Multiomics Characteristics of Infusion Products in Patients with Chronic Lymphocytic Leukemia Treated with CD19 CAR-T Cells. Blood. 138(Supplement 1). 1749–1749. 2 indexed citations
7.
Sheih, Alyssa, Valentin Voillet, Laïla‐Aïcha Hanafi, et al.. (2020). Clonal kinetics and single-cell transcriptional profiling of CAR-T cells in patients undergoing CD19 CAR-T immunotherapy. Nature Communications. 11(1). 219–219. 177 indexed citations
8.
Gauthier, Jordan, Cassie Chou, Alexandre V. Hirayama, et al.. (2020). High IL-15 Serum Concentrations Are Associated with Response to CD19 CAR T-Cell Therapy and Robust In Vivo CAR T-Cell Kinetics. Blood. 136(Supplement 1). 37–38. 8 indexed citations
9.
Gauthier, Jordan, Alexandre V. Hirayama, Janaki Purushe, et al.. (2020). Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure. Blood. 135(19). 1650–1660. 227 indexed citations breakdown →
10.
Hirayama, Alexandre V., Jordan Gauthier, Kevin A. Hay, et al.. (2019). HIGH RATE OF DURABLE COMPLETE REMISSION IN FOLLICULAR LYMPHOMA AFTER CD19 CAR‐T CELL IMMUNOTHERAPY. Hematological Oncology. 37(S2). 170–171. 23 indexed citations
11.
Hay, Kevin A., Jordan Gauthier, Alexandre V. Hirayama, et al.. (2018). Factors impacting disease-free survival in adult B cell B-ALL patients achieving MRD-negative CR after CD19 CAR-T cells.. Journal of Clinical Oncology. 36(15_suppl). 7005–7005. 2 indexed citations
12.
Hirayama, Alexandre V., Jordan Gauthier, Kevin A. Hay, et al.. (2018). Efficacy and Toxicity of JCAR014 in Combination with Durvalumab for the Treatment of Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma. Blood. 132(Supplement 1). 1680–1680. 30 indexed citations
13.
Gauthier, Jordan, Alexandre V. Hirayama, Kevin A. Hay, et al.. (2018). Factors associated with duration of response after CD19-specific CAR-T cell therapy for refractory/relapsed B-cell non-Hodgkin lymphoma.. Journal of Clinical Oncology. 36(15_suppl). 7567–7567. 6 indexed citations
14.
Sheih, Alyssa, Jonathan L. Golob, Abir Bhattacharyya, et al.. (2018). Impact of Intestinal Microbiota on Reconstitution of Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Stem Cell Transplantation. Blood. 132(Supplement 1). 3393–3393. 1 indexed citations
15.
16.
Bhattacharyya, Abir, Laïla‐Aïcha Hanafi, Alyssa Sheih, et al.. (2017). Graft-Derived Reconstitution of Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 24(2). 242–251. 65 indexed citations
17.
Sheih, Alyssa, William C. Parks, & Steven F. Ziegler. (2016). GM-CSF produced by the airway epithelium is required for sensitization to cockroach allergen. Mucosal Immunology. 10(3). 705–715. 47 indexed citations
18.
Kang, Inkyung, Ingrid A. Harten, Mary Y. Chang, et al.. (2016). Versican Deficiency Significantly Reduces Lung Inflammatory Response Induced by Polyinosine-Polycytidylic Acid Stimulation. Journal of Biological Chemistry. 292(1). 51–63. 51 indexed citations
19.
Reeves, Stephen R., Gernot Kaber, Alyssa Sheih, et al.. (2016). Subepithelial Accumulation of Versican in a Cockroach Antigen-Induced Murine Model of Allergic Asthma. Journal of Histochemistry & Cytochemistry. 64(6). 364–380. 22 indexed citations
20.
Sheih, Alyssa, et al.. (2009). Coevolutionary cycling of host sociality and pathogen virulence in contact networks. Journal of Theoretical Biology. 261(4). 561–569. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tatsunori Goto Breakdown of academic impact, for papers by Alexander Jares Breakdown of academic impact, for papers by May Daher Breakdown of academic impact, for papers by Sibylle Pscherer Breakdown of academic impact, for papers by Christos Georgiadis Breakdown of academic impact, for papers by Jessica Hartmann Breakdown of academic impact, for papers by Pranay D. Khare Breakdown of academic impact, for papers by Michael J. Kadan Breakdown of academic impact, for papers by Katrin Töpfer Breakdown of academic impact, for papers by Ruth A. Salmon
Rankless by CCL
2026